SINT
Sintx Technologies, Inc.
Price Chart
Latest Quote
$2.11
+0.08 (+3.94%)
Current Price
| Previous Close | $2.03 |
| Open | $2.04 |
| Day High | $2.15 |
| Day Low | $2.04 |
| Volume | 28,523 |
Stock Information
| Shares Outstanding | 6.20M |
| Total Debt | $3.26M |
| Cash Equivalents | $1.89M |
| Revenue | $1.03M |
| Net Income | $-17.61M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $13.09M |
| EPS (TTM) | $-5.57 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $10.70M |
| Sales | $1.03M |
| Income | $-17.61M |
| Book/sh | $0.22 |
| Cash/sh | $0.30 |
| Employees | 32 |
Financial Ratios
| Quick Ratio | 0.54 |
| Current Ratio | 1.04 |
| Debt/Eq | 360.95 |
Returns & Margins
| ROA | -73.90% |
| ROE | -311.41% |
| Gross Margin | 46.84% |
| Operating Margin | -830.00% |
Ownership
| Insider Ownership | 34.16% |
| Institutional Ownership | 10.12% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.47 |
| P/S | 12.72 |
| P/B | 9.63 |
Analyst Data
| Recommendation | none |
| Target Price | $9.12 |
Technical Indicators
| SMA20 | $2.19 |
| SMA50 | $2.35 |
| SMA200 | $3.22 |
| RSI | 44.63 |
| ATR | 0.1771 |
| Shares Float | 3.44M |
| Short Float | 5.00% |
| Short Ratio | 4.72 |
| Volatility | 0.62 |
| Rel Volume | 0.42 |
Performance History
| Week | -4.52% |
| Month | -4.09% |
| Quarter | -18.22% |
| 6 Months | -40.90% |
| YTD | -44.18% |
| Year | -36.83% |
| 3 Years | -99.36% |
| 5 Years | -99.99% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $2.11 | 30,400 |
| 2026-06-17 | $2.08 | 48,300 |
| 2026-06-16 | $2.16 | 13,100 |
| 2026-06-15 | $2.21 | 10,800 |
| 2026-06-12 | $2.12 | 24,500 |
| 2026-06-11 | $2.21 | 9,800 |
| 2026-06-10 | $2.07 | 29,900 |
| 2026-06-09 | $2.15 | 37,200 |
| 2026-06-08 | $2.07 | 33,200 |
| 2026-06-05 | $2.03 | 116,500 |
| 2026-06-04 | $2.24 | 56,800 |
| 2026-06-03 | $2.24 | 702,500 |
| 2026-06-02 | $2.08 | 79,300 |
| 2026-06-01 | $2.14 | 38,300 |
| 2026-05-29 | $2.24 | 45,100 |
| 2026-05-28 | $2.20 | 43,700 |
| 2026-05-27 | $2.29 | 21,900 |
| 2026-05-26 | $2.43 | 28,300 |
| 2026-05-22 | $2.39 | 65,400 |
| 2026-05-21 | $2.30 | 23,400 |
| 2026-05-20 | $2.21 | 22,500 |
| 2026-05-19 | $2.20 | 34,300 |
About Sintx Technologies, Inc.
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
đ° Latest News
Sintx Technologies Insiders Placed Bullish Bets Worth US$644.2k
Simply Wall St. âĸ 2026-06-12T10:22:26Z
PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-15T13:15:02Z
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-13T22:10:03Z
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates
Zacks âĸ 2025-11-10T14:40:02Z
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
Zacks âĸ 2025-11-06T22:30:03Z
Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates
Zacks âĸ 2025-11-04T13:40:02Z
What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now?
Zacks âĸ 2025-10-16T16:00:02Z
Several Insiders Invested In Sintx Technologies Flagging Positive News
Simply Wall St. âĸ 2025-09-18T11:19:02Z
Top Midday Gainers
MT Newswires âĸ 2025-09-05T17:46:27ZSensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates
Zacks âĸ 2025-08-07T22:35:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $557,000 | $811,000 | $784,000 | $265,000 |
| Cost Of Revenue | $557,000 | $811,000 | $784,000 | $265,000 |
| Total Revenue | $729,000 | $1,246,000 | $1,226,000 | $601,000 |
| Operating Revenue | $729,000 | $1,246,000 | $1,226,000 | $601,000 |
| Expenses | ||||
| Interest Expense | $52,000 | $29,000 | $2,000 | $17,000 |
| Total Expenses | $11,450,000 | $10,284,000 | $14,584,000 | $11,936,000 |
| Other Income Expense | $234,000 | $-2,064,000 | $4,966,000 | $-710,000 |
| Other Non Operating Income Expenses | $31,000 | $39,000 | $17,000 | $382,000 |
| Net Non Operating Interest Income Expense | $123,000 | $78,000 | $133,000 | $6,000 |
| Interest Expense Non Operating | $52,000 | $29,000 | $2,000 | $17,000 |
| Operating Expense | $10,893,000 | $9,473,000 | $13,800,000 | $11,671,000 |
| Other Operating Expenses | $-133,000 | $-339,000 | $-272,000 | $-105,000 |
| Selling And Marketing Expense | $242,000 | $614,000 | $1,137,000 | $1,336,000 |
| General And Administrative Expense | $6,197,000 | $3,997,000 | $4,222,000 | $3,990,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-10,364,000 | $-11,024,000 | $-8,259,000 | $-12,039,000 |
| Net Interest Income | $123,000 | $78,000 | $133,000 | $6,000 |
| Interest Income | $175,000 | $107,000 | $135,000 | $23,000 |
| Normalized Income | $-10,567,000 | $-8,921,000 | $-13,208,000 | $-10,947,000 |
| Net Income From Continuing And Discontinued Operation | $-10,364,000 | $-11,024,000 | $-8,259,000 | $-12,039,000 |
| Total Operating Income As Reported | $-10,721,000 | $-14,047,000 | $-13,358,000 | $-11,335,000 |
| Average Dilution Earnings | $0 | $-291,000 | $-5,320,000 | $-2,807,000 |
| Net Income Common Stockholders | $-17,083,000 | $-11,024,000 | $-8,285,000 | $-16,489,000 |
| Net Income | $-10,364,000 | $-11,024,000 | $-8,259,000 | $-12,039,000 |
| Net Income Including Noncontrolling Interests | $-10,364,000 | $-11,024,000 | $-8,259,000 | $-12,039,000 |
| Net Income Continuous Operations | $-10,364,000 | $-11,024,000 | $-8,259,000 | $-12,039,000 |
| Pretax Income | $-10,364,000 | $-11,024,000 | $-8,259,000 | $-12,039,000 |
| Special Income Charges | $327,000 | $-5,028,000 | $17,000 | $-1,000 |
| Interest Income Non Operating | $175,000 | $107,000 | $135,000 | $23,000 |
| Operating Income | $-10,721,000 | $-9,038,000 | $-13,358,000 | $-11,335,000 |
| Gross Profit | $172,000 | $435,000 | $442,000 | $336,000 |
| Per Share | ||||
| Diluted EPS | $-6.16 | $-15.19 | $-624.47 | $-12162.00 |
| Basic EPS | $-6.16 | $-14.87 | $-443.47 | $-10934.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,853,000 | $-7,508,000 | $-11,549,000 | $-9,967,000 |
| Total Unusual Items | $203,000 | $-2,103,000 | $4,949,000 | $-1,092,000 |
| Total Unusual Items Excluding Goodwill | $203,000 | $-2,103,000 | $4,949,000 | $-1,092,000 |
| Reconciled Depreciation | $662,000 | $1,384,000 | $1,657,000 | $963,000 |
| EBITDA (Bullshit earnings) | $-9,650,000 | $-9,611,000 | $-6,600,000 | $-11,059,000 |
| EBIT | $-10,312,000 | $-10,995,000 | $-8,257,000 | $-12,022,000 |
| Diluted Average Shares | $2,773,518 | $744,782 | $21,786 | $1,586 |
| Basic Average Shares | $2,773,518 | $741,250 | $18,682 | $1,508 |
| Diluted NI Availto Com Stockholders | $-17,083,000 | $-11,315,000 | $-13,605,000 | $-19,296,000 |
| Preferred Stock Dividends | $6,719,000 | - | $26,000 | $4,450,000 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Ppe | $327,000 | $-19,000 | $17,000 | $-1,000 |
| Restructuring And Mergern Acquisition | $0 | $5,009,000 | $0 | - |
| Gain On Sale Of Security | $-124,000 | $2,925,000 | $4,932,000 | $-1,091,000 |
| Research And Development | $4,587,000 | $5,201,000 | $8,713,000 | $6,450,000 |
| Selling General And Administration | $6,439,000 | $4,611,000 | $5,359,000 | $5,326,000 |
| Other Gand A | $6,197,000 | $3,997,000 | $4,222,000 | $3,990,000 |
| Otherunder Preferred Stock Dividend | - | - | - | $4,450,000 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,485,000 | $3,878,000 | $8,751,000 | $5,678,000 |
| Total Assets | $9,506,000 | $9,413,000 | $15,365,000 | $15,773,000 |
| Total Non Current Assets | $3,856,000 | $4,892,000 | $9,833,000 | $8,564,000 |
| Other Non Current Assets | $478,000 | $795,000 | $892,000 | $538,000 |
| Goodwill And Other Intangible Assets | $444,000 | $16,000 | $21,000 | $26,000 |
| Other Intangible Assets | $142,000 | $16,000 | $21,000 | $26,000 |
| Current Assets | $5,650,000 | $4,521,000 | $5,532,000 | $7,209,000 |
| Other Current Assets | $507,000 | $225,000 | $619,000 | $352,000 |
| Inventory | $825,000 | $502,000 | $888,000 | $284,000 |
| Receivables | $178,000 | $196,000 | $685,000 | $328,000 |
| Accounts Receivable | $178,000 | $196,000 | $685,000 | $328,000 |
| Allowance For Doubtful Accounts Receivable | $-2,400 | $-61,000 | $-72,000 | $-7,000 |
| Gross Accounts Receivable | $180,400 | $257,000 | $757,000 | $335,000 |
| Cash Cash Equivalents And Short Term Investments | $4,140,000 | $3,598,000 | $3,340,000 | $6,245,000 |
| Cash And Cash Equivalents | $4,140,000 | $3,598,000 | $3,340,000 | $6,245,000 |
| Prepaid Assets | - | - | - | $344,000 |
| Notes Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | $3,249,000 | $4,025,000 | $4,245,000 | $2,887,000 |
| Long Term Debt And Capital Lease Obligation | $2,844,000 | $3,537,000 | $3,687,000 | $1,989,000 |
| Current Debt And Capital Lease Obligation | $405,000 | $488,000 | $558,000 | $898,000 |
| Current Debt | $7,000 | $32,000 | $46,000 | $160,000 |
| Other Current Borrowings | $7,000 | $32,000 | $46,000 | $160,000 |
| Long Term Debt | - | - | - | $368,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,577,000 | $5,519,000 | $6,593,000 | $10,069,000 |
| Total Non Current Liabilities Net Minority Interest | $2,844,000 | $3,537,000 | $3,687,000 | $1,991,000 |
| Current Liabilities | $3,733,000 | $1,982,000 | $2,906,000 | $8,078,000 |
| Other Current Liabilities | $2,524,000 | $209,000 | $308,000 | $5,128,000 |
| Payables And Accrued Expenses | $804,000 | $1,285,000 | $2,040,000 | $2,052,000 |
| Payables | $432,000 | $477,000 | $799,000 | $898,000 |
| Other Payable | $50,000 | $178,000 | $163,000 | $464,000 |
| Accounts Payable | $382,000 | $299,000 | $636,000 | $434,000 |
| Other Non Current Liabilities | - | - | - | $2,000 |
| Equity | ||||
| Common Stock Equity | $2,929,000 | $3,894,000 | $8,772,000 | $5,704,000 |
| Total Equity Gross Minority Interest | $2,929,000 | $3,894,000 | $8,772,000 | $5,704,000 |
| Stockholders Equity | $2,929,000 | $3,894,000 | $8,772,000 | $5,704,000 |
| Retained Earnings | $-292,102,000 | $-281,738,000 | $-270,714,000 | $-262,455,000 |
| Other | ||||
| Treasury Shares Number | $50,424 | - | $0 | - |
| Ordinary Shares Number | $3,920,445 | $1,342,853 | $26,603 | $2,710 |
| Share Issued | $3,970,869 | $1,342,853 | $26,603 | $2,710 |
| Tangible Book Value | $2,485,000 | $3,878,000 | $8,751,000 | $5,678,000 |
| Invested Capital | $2,936,000 | $3,926,000 | $8,818,000 | $6,232,000 |
| Working Capital | $1,917,000 | $2,539,000 | $2,626,000 | $-869,000 |
| Capital Lease Obligations | $3,242,000 | $3,993,000 | $4,199,000 | $2,359,000 |
| Total Capitalization | $2,929,000 | $3,894,000 | $8,772,000 | $6,072,000 |
| Treasury Stock | $133,000 | $0 | - | - |
| Additional Paid In Capital | $295,124,000 | $285,619,000 | $279,486,000 | $268,154,000 |
| Capital Stock | $40,000 | $13,000 | $0 | $5,000 |
| Common Stock | $40,000 | $13,000 | $0 | $5,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $2,844,000 | $3,537,000 | $3,687,000 | $1,621,000 |
| Current Capital Lease Obligation | $398,000 | $456,000 | $512,000 | $738,000 |
| Current Accrued Expenses | $372,000 | $808,000 | $1,241,000 | $1,154,000 |
| Goodwill | $302,000 | $0 | - | - |
| Net PPE | $2,934,000 | $4,081,000 | $8,920,000 | $8,000,000 |
| Accumulated Depreciation | $-3,052,000 | $-3,048,000 | $-3,692,000 | $-2,312,000 |
| Gross PPE | $5,986,000 | $7,129,000 | $12,612,000 | $10,312,000 |
| Leases | $989,000 | $968,000 | $2,034,000 | $951,000 |
| Other Properties | $4,241,000 | $5,379,000 | $9,691,000 | $8,501,000 |
| Machinery Furniture Equipment | $756,000 | $782,000 | $887,000 | $860,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | - | - | - | - |
| Work In Process | - | - | - | - |
| Raw Materials | - | - | - | - |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-8,760,000 | $-9,332,000 | $-14,645,000 | $-11,668,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-8,571,000 | $-8,642,000 | $-14,115,000 | $-10,263,000 |
| Cash Flow From Continuing Operating Activities | $-8,571,000 | $-8,642,000 | $-14,115,000 | $-10,263,000 |
| Operating Gains Losses | $-203,000 | $-3,457,000 | $-5,627,000 | $1,092,000 |
| Investing Activities | ||||
| Capital Expenditure | $-189,000 | $-690,000 | $-530,000 | $-1,405,000 |
| Investing Cash Flow | $913,000 | $-194,000 | $-501,000 | $-1,101,000 |
| Cash Flow From Continuing Investing Activities | $913,000 | $-194,000 | $-501,000 | $-1,101,000 |
| Net Other Investing Changes | - | $476,000 | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-133,000 | $0 | $-2,000 | $0 |
| Issuance Of Capital Stock | $329,000 | $0 | $0 | $3,845,000 |
| Financing Cash Flow | $8,200,000 | $9,094,000 | $11,711,000 | $3,336,000 |
| Cash Flow From Continuing Financing Activities | $8,200,000 | $9,092,000 | $11,711,000 | $3,336,000 |
| Net Common Stock Issuance | $196,000 | $0 | - | - |
| Common Stock Issuance | $329,000 | $0 | - | - |
| Net Other Financing Charges | - | $3,368,000 | $6,650,000 | - |
| Net Preferred Stock Issuance | - | $0 | $-2,000 | $3,845,000 |
| Preferred Stock Issuance | - | - | $0 | $3,845,000 |
| Other | ||||
| Repayment Of Debt | $-206,000 | $-349,000 | $-114,000 | $-509,000 |
| Interest Paid Supplemental Data | $52,000 | $29,000 | $21,000 | $1,000 |
| End Cash Position | $4,140,000 | $3,598,000 | $3,340,000 | $6,245,000 |
| Beginning Cash Position | $3,598,000 | $3,340,000 | $6,245,000 | $14,273,000 |
| Changes In Cash | $542,000 | $258,000 | $-2,905,000 | $-8,028,000 |
| Proceeds From Stock Option Exercised | $8,210,000 | $6,075,000 | $5,177,000 | $0 |
| Common Stock Payments | $-133,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $-206,000 | $-349,000 | $-114,000 | $-509,000 |
| Net Long Term Debt Issuance | $-206,000 | $-349,000 | $-114,000 | $-509,000 |
| Long Term Debt Payments | $-206,000 | $-349,000 | $-114,000 | $-509,000 |
| Net PPE Purchase And Sale | $913,000 | $-670,000 | $-501,000 | $-1,404,000 |
| Sale Of PPE | $1,102,000 | $20,000 | $29,000 | $1,000 |
| Purchase Of PPE | $-189,000 | $-690,000 | $-530,000 | $-1,405,000 |
| Change In Working Capital | $-356,000 | $286,000 | $-1,551,000 | $-55,000 |
| Change In Other Current Liabilities | $45,000 | $-2,000 | $-370,000 | $-128,000 |
| Change In Payables And Accrued Expense | $-200,000 | $-756,000 | $-12,000 | $226,000 |
| Change In Prepaid Assets | $-47,000 | $482,000 | $-264,000 | $13,000 |
| Change In Inventory | $-85,000 | $72,000 | $-485,000 | $-140,000 |
| Change In Receivables | $-69,000 | $490,000 | $-420,000 | $-26,000 |
| Other Non Cash Items | $-367,000 | $-514,000 | $-626,000 | $-593,000 |
| Stock Based Compensation | $1,996,000 | $82,000 | $291,000 | $369,000 |
| Asset Impairment Charge | $61,000 | $4,601,000 | $0 | $-7,000 |
| Depreciation Amortization Depletion | $662,000 | $1,384,000 | $1,657,000 | $963,000 |
| Depreciation And Amortization | $662,000 | $1,384,000 | $1,657,000 | $963,000 |
| Amortization Cash Flow | $19,000 | $5,000 | $5,000 | $5,000 |
| Amortization Of Intangibles | $19,000 | $5,000 | $5,000 | $5,000 |
| Depreciation | $643,000 | $1,379,000 | $1,652,000 | $958,000 |
| Gain Loss On Investment Securities | $124,000 | $-3,475,000 | $-5,610,000 | $1,091,000 |
| Gain Loss On Sale Of PPE | $-352,000 | $18,000 | $-17,000 | $1,000 |
| Gain Loss On Sale Of Business | $25,000 | $0 | - | - |
| Net Income From Continuing Operations | $-10,364,000 | $-11,024,000 | $-8,259,000 | $-12,039,000 |
| Preferred Stock Payments | - | $0 | $-2,000 | $0 |
| Net Business Purchase And Sale | - | - | $0 | $303,000 |
| Sale Of Business | - | - | $0 | $303,000 |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-06-16